Acrospire Investment Management LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 41 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$16,000
-38.5%
2,782
-37.9%
0.02%
-28.6%
Q1 2017$26,000
+36.8%
4,482
+21.7%
0.02%
+162.5%
Q4 2016$19,000
-5.0%
3,682
-62.9%
0.01%
-38.5%
Q3 2016$20,000
+122.2%
9,914
+119.9%
0.01%
+85.7%
Q2 2016$9,000
+350.0%
4,509
+457.4%
0.01%
+600.0%
Q1 2016$2,0008090.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders